StockNews.AI
USNA
StockNews.AI
119 days

USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

1. USANA's Q1 2025 sales grew 10% year-over-year to $250 million. 2. Net earnings decreased to $9.4 million, impacting EPS from $0.86 to $0.49.

Earnings
+4.91%Current Return
VS
+1.59%S&P 500
$24.2404/22 04:15 PM EDTEvent Start
$25.4304/23 10:51 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

Despite growth in sales, the significant drop in earnings and EPS suggests potential concerns for investors. Historical data illustrates that declines in earnings often lead to reduced investor confidence and stock price pressure.

How important is it?

The earnings report is crucial as it directly influences investor sentiment and expectation management; lower earnings can lead to stock sell-offs.

Why Short Term?

The immediate drop in earnings and EPS will likely affect investor sentiment quickly, leading to potential price declines within the next few months, similar to past quarterly report reactions.

Related Companies

Nutritional ProductsVitaCost
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency. Net earnings of $9.4 million versus $16.5 million. Diluted EPS of $0.49 as compared with $0.86. Adjusted diluted EPS(1) of $0.73 as compared with $0.86. Adju.

Related News